VYNE Therapeutics, Inc. (VYNE)
0.6101
-0.01
(-2.35%)
USD |
NASDAQ |
Apr 14, 16:00
0.6101
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Profit Margin (Quarterly) : -3.82K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | -29.49% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.57% |
| Return on Assets | -57.05% |
| Return on Invested Capital | -68.50% |
| Gross Profit Margin (Quarterly) | 96.15% |
| Operating Margin (Quarterly) | -4.01K% |
| Return on Net Operating Assets | -19.23K% |